ShareHope Medicine Co., Ltd. (TPEX:8403)
19.30
-0.20 (-1.03%)
Jul 17, 2026, 1:30 PM CST
ShareHope Medicine Revenue
ShareHope Medicine had revenue of 1.08B TWD in the quarter ending March 31, 2026, with 2.42% growth. This brings the company's revenue in the last twelve months to 4.38B, down -0.49% year-over-year. In the year 2025, ShareHope Medicine had annual revenue of 4.36B with 0.74% growth.
Revenue (ttm)
4.38B
Revenue Growth
-0.49%
P/S Ratio
0.61
Revenue / Employee
37.15M
Employees
118
Market Cap
2.66B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.36B | 32.04M | 0.74% |
| Dec 31, 2024 | 4.33B | 452.45M | 11.68% |
| Dec 31, 2023 | 3.87B | -263.75M | -6.38% |
| Dec 31, 2022 | 4.14B | 287.10M | 7.46% |
| Dec 31, 2021 | 3.85B | -248.85M | -6.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 17.50B |
| Maywufa Company | 1.61B |
| Qing Song Health | 1.17B |
| MARX Biotech | 635.85M |
| Applied BioCode | 572.33M |
| Intech Biopharm | 117.49M |
| Caliway Biopharmaceuticals | 38.04M |
| GlycoNex Incorporation | 36.35M |